<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940627-0-00248</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=11 g=1 f=1 --> ( <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> i <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ) At the time of sacrifice on gestation day 20 or at  <!-- PJG 0012 frnewline --> death during the study, each dam shall be examined  <!-- PJG 0012 frnewline --> macroscopically for any structural abnormalities or pathological  <!-- PJG 0012 frnewline --> changes which may have influenced the pregnancy.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  ( <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> ii <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ) The contents of the uterus shall be examined for  <!-- PJG 0012 frnewline --> embryonic or fetal deaths and the number of viable fetuses.  <!-- PJG 0012 frnewline --> Gravid uterine weights need not be obtained from dead animals  <!-- PJG 0012 frnewline --> where decomposition has occurred. The degree of resorption shall  <!-- PJG 0012 frnewline --> be described in order to help estimate the relative time of  <!-- PJG 0012 frnewline --> death.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  ( <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> iii <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ) The number of corpora lutea shall be determined in  <!-- PJG 0012 frnewline --> each pregnant dam.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  ( <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> iv <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ) Each fetus shall be weighed, all weights recorded, and  <!-- PJG 0012 frnewline --> mean fetal weights determined.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  ( <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> v <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ) Each fetus shall be examined externally and the sex  <!-- PJG 0012 frnewline --> determined.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  ( <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> vi <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ) One-half of the rat fetuses in each litter shall be  <!-- PJG 0012 frnewline --> examined for skeletal anomalies, and the remaining half shall be  <!-- PJG 0012 frnewline --> examined for soft tissue anomalies, using appropriate methods.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (ii)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Histopathology. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  (A) Histopathology on vagina, uterus, ovaries, testes, epididymides, seminal vesicles, and prostate as appropriate for all males and histology group females in the control and high concentration groups and for all animals that died or were euthanized during the study. If abnormalities or equivocal results are seen in any of these organs/tissues, the same organ/tissue from test animals in lower concentration groups shall be examined. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=4 --> Note:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> Testes, seminal vesicles, epididymides, and ovaries, at a minimum, shall be examined in perfusion-fixed (pressure or gravity method) test subjects, when available.  <!-- PJG 0012 frnewline -->   <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->   <!-- PJG ITAG l=11 g=1 f=1 --> (B) All gross lesions in all study animals shall be  <!-- PJG 0012 frnewline --> examined.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (C) As noted under mating procedures, reproductive organs  <!-- PJG 0012 frnewline --> of animals suspected of infertility shall be subject to  <!-- PJG 0012 frnewline --> microscopic examination.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (D) The following organs and tissues, or representative  <!-- PJG 0012 frnewline --> samples thereof, shall be preserved in a suitable medium for  <!-- PJG 0012 frnewline --> future histopathological examination: all gross lesions; vagina;  <!-- PJG 0012 frnewline --> uterus; ovaries; testes; epididymides; seminal vesicles;  <!-- PJG 0012 frnewline --> prostate; liver; and kidneys/adrenals.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (3)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Evaluation of results. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  (i) The findings of a developmental toxicity study shall be evaluated in terms of the observed effects and the exposure levels producing effects. It is necessary to consider the historical developmental toxicity data on the species/strain tested.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (ii) There are several criteria for determining a positive  <!-- PJG 0012 frnewline --> result for reproductive/teratologic effects; a statistically  <!-- PJG 0012 frnewline --> significant dose-related decrease in the weight of the testes for  <!-- PJG 0012 frnewline --> treated subjects over control subjects, a decrease in neonatal  <!-- PJG 0012 frnewline --> viability, a significant change in the presence of soft tissue or  <!-- PJG 0012 frnewline --> skeletal abnormalities, or an increased rate of embryonic or  <!-- PJG 0012 frnewline --> fetal resorption or death. Other criteria, e.g., lengthening of  <!-- PJG 0012 frnewline --> the estrous cycle or the time spent in any one stage of estrus,  <!-- PJG 0012 frnewline --> changes in the proportion of viable male vs female fetuses or  <!-- PJG 0012 frnewline --> offspring, the number and type of cells in vaginal smears, or  <!-- PJG 0012 frnewline --> pathologic changes found during gross or microscopic examination  <!-- PJG 0012 frnewline --> of male or female reproductive organs may be based upon detection  <!-- PJG 0012 frnewline --> of a reproducible and statistically significant positive response  <!-- PJG 0012 frnewline --> for that evaluation parameter. A positive result indicates that,  <!-- PJG 0012 frnewline --> under the test conditions, the test substance does induce  <!-- PJG 0012 frnewline --> reproductive organ or fetal toxicity in the test species.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (iii) A test substance which does not produce either a  <!-- PJG 0012 frnewline --> statistically significant dose-related change in the reproductive  <!-- PJG 0012 frnewline --> organs or cycle or a statistically significant and reproducible  <!-- PJG 0012 frnewline --> positive response at any one of the test points may not induce  <!-- PJG 0012 frnewline --> reproductive organ toxicity in this test species, but further  <!-- PJG 0012 frnewline --> investigation , e.g., to establish absorption and bioavailability  <!-- PJG 0012 frnewline --> of the test substance, should be considered.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (h)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Test report. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  In addition to the reporting requirements  <!-- PJG 0012 frnewline --> as specified under 40 CFR 79.60 and the vehicle emissions  <!-- PJG 0012 frnewline --> inhalation toxicity guideline as published in 40 CFR 79.61, the  <!-- PJG 0012 frnewline --> following specific information shall be reported:  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (1)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Individual animal data. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  (i) Time of death during the study or whether animals survived to termination.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (ii) Date of onset and duration of each abnormal sign and  <!-- PJG 0012 frnewline --> its subsequent course.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (iii) Feed and body weight data.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (iv) Necropsy findings.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (v) Male test subjects.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (A) Testicle weight, and body weight: testicle weight ratio.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (B) Detailed description of all histopathological findings,  <!-- PJG 0012 frnewline --> especially for the testes and the epididymides.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (vi) Female test subjects.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            